Maternal autoimmune rheumatic diseases can influence the outcomes of children through
several life stages. During pregnancy, maternal inflammation and autoantibodies can hinder …

Active inflammatory arthritis in pregnancy is associated with an increased risk of adverse
pregnancy outcomes. Treatment of active inflammation and maintenance of low disease …

Background Evidence on ustekinumab safety in pregnancy is gradually expanding, but its
clearance in the postnatal period is unknown. The aim of this study was to investigate …

Inflammatory bowel disease (IBD) affects reproductive planning due to psychological effects
and mechanical problems related to surgery. Children of people with IBD have an increased …

Background & Aims Vedolizumab and ustekinumab pharmacokinetics in pregnancy and the
infant after in utero exposure remain incompletely defined. We aim to define the antenatal …

With the rapid development of tumor immunotherapy, nanoparticle vaccines have attracted
much attention as potential therapeutic strategies. A systematic review and analysis must be …

Background In infants that were exposed to biologics in utero, gastroenterology societal
guidelines have either recommended against administration of the live rotavirus vaccine …

Background & Aims Biologic therapies in the context of inflammatory bowel disease and
pregnancy lead to improved maternal and fetal outcomes. Placental transfer results in …

Data on the real long-term influences of in utero drug exposure in pregnant women on
childhood development are scarce and remain not well determined and depend on the …

Introduction: Errors are very common in medical practice and in particular, in the healthcare
of patients with inflammatory bowel disease (IBD); however, most of these can be prevented …